What AiiNTENSE does

AiiNTENSE SAS is a French medical data engineering company founded in September 2018 and headquartered at the Genopole Campus 3 incubator in Évry-Courcouronnes, Île-de-France. The company builds AI-driven clinical decision-support and medical-research platforms focused on neurosciences and intensive care, serving hospital neurologists, neuro-reanimators, intensivists and clinical researchers. Its product portfolio centres on two core platforms — D'Open Clinics, a clinical-facing application that integrates the proprietary StruX NLP module, cognitive decision-support assistants, a unified patient dashboard, and a tele-expertise / tele-RCP service; and D'Open Analytics, a research-facing suite that uses StruX to convert unstructured hospital text into multimodal qualitative databases. A Parkinson's-specific extension, e-ParKare, integrated with DiamPark's medical monitoring device, was launched in February 2024, and the COVID-era NeuroCOVID tele-expertise platform (100+ on-call experts, 32 centres, free during the crisis) established the company's expert-network and brand credibility.

The founding team combines ex-IBM entrepreneur Daniel Duhautbout (CEO), data engineer Philippe Deconinck (CTO) and hospital-efficiency specialist Pierre Rocheteau (Business Advisor), alongside clinical founders intensivists Pr Tarek Sharshar (GHU Paris Sainte-Anne) and Dr Aurélien Mazeraud. AiiNTENSE generates revenue primarily through subscription or enterprise licensing of D'Open Clinics and D'Open Analytics to hospitals and research centres, complemented by distribution-based revenue from its 2021 commercial representation agreement with Epimed Solutions for the French market, and by professional services for integration and deployment; a freemium registration tier is offered to individual clinicians. Go-to-market blends direct enterprise sales, channel partnerships (Epimed, Genopole, EIT Health, IMT Starter) and visibility activity at CES Las Vegas 2020 and the Silicon Awards 2022. Named partners and pilot users include GHU Paris Psychiatrie & Neurosciences, CHU de Nice, Centre Hospitalier Sud Francilien, ARS Île-de-France, Talan Labs, DiamPark and the CYBAILE chair (Thales, Sophia Genetics, LaTIM Inserm); headcount is 1-10 and only one disclosed funding event exists ($67,314 from IMT Starter, January 2020), indicating an early-stage, founder-financed operating profile.

Geographically the company serves France directly with international reach mediated through Epimed's European and Latin American hospital footprint; integrations span the DPI (Dossier Patient Informatisé), DMP (Dossier Médical Partagé), Epimed Monitor and DiamPark devices. The company states GDPR compliance and is operating under French regulatory exposure for any clinical decision-support module that qualifies as a medical device.

Name

AiiNTENSE

Legal name

AiiNTENSE SAS

Website

https://aiintense.eu

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

AiiNTENSE is a French medical AI company that builds clinical decision support and research data platforms for neurosciences and intensive care, serving hospitals, neurologists, and clinical researchers via its D'Open Clinics, D'Open Analytics, StruX, and e-ParKare products.

Ownership category

akta.pro rank

Product category

Healthcare Clinical Decision Support Software

NAICS

Offices of Physicians, Mental Health Specialists (621112), Custom Computer Programming Services (541511), Computer Systems Design Services (541512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurology Telemedicine Platforms (HLALAGAC)

akta.pro secondary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Clinical decision support
• Medical data engineering
• Tele-expertise services
• Neurological monitoring software
• Healthcare AI platforms

Headquarters

HQ city

Évry

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Platform Licensing (D'Open Clinics & D'Open Analytics): AiiNTENSE offers its medical software platforms to hospitals, clinics, and healthcare institutions. The platforms provide clinical decision support, tele-expertise, and data analytics services. Revenue likely derives from platform subscriptions or licensing to healthcare institutions.
2. Distribution Partnership Revenue (Epimed Solutions): AiiNTENSE serves as commercial representative of Epimed Solutions in France, distributing Epimed's quality management and efficiency tools for intensive care and resuscitation services to French hospitals.
3. e-ParKare Parkinson's Care Solutions: Integrated care management solution for Parkinson's patients including medical devices and telemedicine services, built in collaboration with DiamPark.
4. Professional Services & Implementation: Technical integration, deployment support, and customization services for healthcare institutions implementing AiiNTENSE platforms.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

AiiNTENSE develops AI-powered clinical decision-support and medical data engineering platforms for neurosciences and intensive care. Its core offerings include D'Open Clinics (a clinician-facing platform integrating patient data collection, cognitive decision-support assistants, and tele-expertise/tele-RCP services for neurologists and ICU physicians) and D'Open Analytics (a researcher-facing suite using the proprietary StruX NLP technology to extract, structure, and normalize unstructured medical text into multimodal research databases). It also offers e-ParKare, a holistic Parkinson's disease care solution integrating a DiamPark medical monitoring device with collaborative telemedicine tools.

Product overview

AiiNTENSE is a medical data engineering company specializing in neurosciences and critical care. Its product portfolio consists of two core platforms — D'Open Clinics for clinicians and D'Open Analytics for researchers — supported by the named StruX NLP/text-processing module. D'Open Clinics integrates patient data collection, cognitive AI decision-support assistants, tele-expertise/Tele-RCP services, and a unified patient dashboard. D'Open Analytics uses StruX to build multimodal research databases from unstructured medical text. The e-ParKare solution extends the platform to Parkinson's disease care, integrating a medical monitoring device from DiamPark with AiiNTENSE's telemedicine tools. A COVID-era tele-expertise platform, NeuroCOVID, was launched on top of these capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• D'Open Clinics: Clinical decision support platform and tele-expertise solution for neurologists and intensive care physicians.
• D'Open Analytics
• e-ParKare
• NeuroMonitor

Products and services

• D'Open Clinics A comprehensive software platform for neurologists and intensive care physicians for prediction and monitoring of patients' neurological state. It integrates patient data collection, cognitive AI decision-support assistants, and tele-expertise/tele-RCP services within a unified dashboard interface. Target users are hospital neurologists, neuro-reanimation specialists, and ICU physicians.
• D'Open Analytics A suite of technologies for building multimodal, qualitative medical research databases retrospectively or prospectively, rapidly and economically. It integrates the proprietary StruX data extraction and structuring technology for converting unstructured medical text into structured, exploitable databases. Targeted at clinical researchers and neuroscience laboratories.
• e-ParKare A holistic personalized care management solution for patients with Parkinson's disease. It integrates DiamPark's medical monitoring device for symptom capture, AiiNTENSE's collaborative telemedicine solutions, direct physician assistance, and innovative paramedic coordination. Targets Parkinson's patients, general practitioners, neurologists, and healthcare establishments.
• NeuroCOVID A tele-expertise platform launched during the COVID-19 pandemic providing 24/7 access to over 100 neurology and neuro-reanimation experts in permanent on-call duty for physicians treating patients with neurological conditions. It facilitated care pathways during the pandemic and was deployed in partnership with regional health authorities including ARS Ile de France.

Quantifiable outcome

• Data precision rates exceeding 95%
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature6 records

Partnerships

14 partnerships are on record, tiered core, major and minor.

• GHU Paris Psychiatrie & NeurosciencescoreStrategic or Co-development Partner · 1 December 2022Partnership for development of NeuroMonitor platform - tools for structuring textual data and semantic enrichment of health data warehouses. GHU Paris contributes clinical expertise and data for development of medical decision support tools and tele-expertise applications.
• CYBAILE (Thales, Sophia Genetics, LaTIM Inserm UMR 1101)majorStrategic or Co-development Partner · 1 December 2021AiiNTENSE leads security of predictive tools in neurosciences within CYBAILE research chair. Partnership combines academic and industrial expertise in cybersecurity, AI, and health domain to develop trusted, secure AI in healthcare. Supported by Brittany region.
• Epimed SolutionscoreChannel Partner/ Reseller/ Distributor · 1 June 2021Strategic partnership for distribution of Epimed Solutions' quality management and efficiency tools for intensive care and resuscitation services in France. AiiNTENSE became Epimed's commercial representative in France.
• Talan / TalanLabscoreTechnology or Integration · 1 April 2021Strategic partnership for co-development of AI-based medical decision support solutions for intensive care with focus on neurological pathologies. Companies collaborated for two years prior to formal partnership. Aims to create interoperable solutions across hospital software systems.
• VCLS / NeighborhoodmajorImplementation/ SI/ Consulting Partner · 1 May 2020Neighborhood innovation center selected AiiNTENSE for its 2-year mentoring program. Program provides regulatory strategy, clinical development, manufacturing guidance, access to health tech decision-maker network, and workspace in Boulogne, Lausanne, and Boston.
• GHU Paris Sainte-AnnecoreStrategic or Co-development PartnerClinical research partnership with neuro-reanimation department led by Pr Tarek Sharshar. Hospital provides medical expertise for platform development and validation of algorithms.
• CHU de NicemajorStrategic or Co-development PartnerHealthcare institution partner participating in pilot deployment of medical tools and protocols adapted for clinical use by healthcare teams.
• Centre Hospitalier Sud Francilien (CHSF)majorStrategic or Co-development PartnerHealthcare institution using beta versions of tools for innovation in design and execution of medical research projects.
• DiamPark (diampark.io)majorTechnology or IntegrationTechnology partnership for e-ParKare solution. DiamPark provides medical monitoring device for Parkinson's symptom capture; AiiNTENSE provides collaborative telemedicine solutions.
• GenopolecoreOthersBiotech incubator co-incubating AiiNTENSE at Genopole Campus 3 in Evry. Provides startup support and ecosystem access.
• IMT StartercoreOthersTelecom institute startup accelerator co-incubating AiiNTENSE. Provides startup support and innovation ecosystem access.
• EIT HealthmajorOthersEuropean health innovation network providing acceleration support and ecosystem access for AiiNTENSE.
• Métropole Nice Côte d'AzurminorOthersRegional metropolitan authority providing acceleration support to AiiNTENSE.
• Deloitte FranceminorGTM or Marketing PartnerProvided recognition and visibility at CES Las Vegas through Prix Innovation Bercy/IMT partnership. Supported innovation prize category sponsorship.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Nabla: Nabla is a French-founded AI company providing ambient clinical documentation and decision-support tools for physicians. Comparable in its use of NLP on clinical text to relieve physician documentation burden, overlapping partially with StruX and cognitive decision assistants; broader in primary care rather than neurology-specific.
• Abridge: Abridge is a US-based clinical NLP/ambient AI company that converts patient-clinician conversations into structured clinical notes. Comparable to AiiNTENSE in applying large-language-model-style text extraction to clinical workflows, but operating in general medical specialties with a stronger commercial scale and US footprint.

Direct peers

• Posos: Posos is a French clinical decision-support platform that uses AI to help physicians with prescribing, diagnosis, and treatment decisions in real time. Closely comparable to AiiNTENSE in target users (hospital physicians), geography (France), and core function (AI-augmented clinical decision support), though Posos focuses more on medication and general practice than neurology.
• Kayentis: Kayentis is a French vendor of eCOA/ePRO and clinical trial data collection technologies for pharma-sponsored research. Directly comparable to AiiNTENSE's D'Open Analytics and StruX in terms of capturing patient-facing clinical data into structured research databases, with overlap in pharmaceutical and academic research customers.
• Qare: Qare is a French subscription-based telemedicine platform offering remote consultations across specialties including mental health. Directly comparable to AiiNTENSE's tele-expertise and e-ParKare telemedicine capabilities, particularly in serving French patients and providers remotely.
• Incepto Medical: Incepto Medical is a French AI platform aggregating and distributing medical imaging AI applications to European hospitals. Comparable as a fellow French hospital-focused AI vendor working in partnership with public hospital networks, though its applications center on imaging rather than AiiNTENSE's text/clinical decision support niche.
• Castor: Castor is a clinical research data capture platform used to structure patient data for trials and registries. Comparable to AiiNTENSE's D'Open Analytics and StruX in converting unstructured clinical inputs into structured research databases, with similar customer segments in pharma-sponsored research and academic medical centers.

Broad incumbents

• Voluntis (AstraZeneca): Voluntis, now part of AstraZeneca, develops digital therapeutics and RPM software for chronic conditions. Comparable to AiiNTENSE's e-ParKare solution for Parkinson's disease in combining medical monitoring devices, software, and care coordination for chronic specialty conditions.
• Nuance (Microsoft DAX): Nuance, now part of Microsoft, is the dominant vendor of clinical speech recognition and ambient documentation (DAX Copilot) for hospitals globally. Broadly comparable in clinical NLP and decision-support positioning to StruX and D'Open Clinics, but as a multinational incumbent offers an enterprise-wide suite rather than a neuroscience-specific product.
• Doctolib: Doctolib is the dominant French digital health platform for appointment booking, telemedicine, and physician software. Comparable as the incumbent French health-tech ecosystem that hospitals and clinicians already use, and a potential integrator/competitor for any telemedicine or tele-expertise workflows AiiNTENSE seeks to expand into.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AiiNtense
• YouTubeyoutube.com/channel/UCQBHkTlJUvQYuG3p1Jtg4WA
• LinkedInlinkedin.com/company/aiintense

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AiiNTENSE